BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26163541)

  • 1. Influence of drug therapy on the risk of recurrence of ocular toxoplasmosis.
    Reich M; Becker MD; Mackensen F
    Br J Ophthalmol; 2016 Feb; 100(2):195-9. PubMed ID: 26163541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular Toxoplasmosis in a Tertiary Referral Center in Sydney Australia-Clinical Features, Treatment, and Prognosis.
    Yates WB; Chiong F; Zagora S; Post JJ; Wakefield D; McCluskey P
    Asia Pac J Ophthalmol (Phila); 2019; 8(4):280-284. PubMed ID: 31369405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time PCR using the 529 bp repeat element for the diagnosis of atypical ocular toxoplasmosis.
    Steeples LR; Guiver M; Jones NP
    Br J Ophthalmol; 2016 Feb; 100(2):200-3. PubMed ID: 26174811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value of Positive Findings of
    Park SW; Kim SH; Kwon HJ; Lee SM; Byon IS; Lee JE
    Ocul Immunol Inflamm; 2019; 27(4):583-590. PubMed ID: 29513626
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and Biological Factors Associated With Recurrences of Severe Toxoplasmic Retinochoroiditis Confirmed by Aqueous Humor Analysis.
    Matet A; Paris L; Fardeau C; Terrada C; Champion E; Fekkar A; Cassoux N; Touitou V; LeHoang P; Bodaghi B
    Am J Ophthalmol; 2019 Mar; 199():82-93. PubMed ID: 30502335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Therapy of Acquired Ocular Toxoplasmosis: A Review.
    Lima GS; Saraiva PG; Saraiva FP
    J Ocul Pharmacol Ther; 2015 Nov; 31(9):511-7. PubMed ID: 26226199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time patterns of recurrences and factors predisposing for a higher risk of recurrence of ocular toxoplasmosis.
    Reich M; Ruppenstein M; Becker MD; Mackensen F
    Retina; 2015 Apr; 35(4):809-19. PubMed ID: 25299969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological Diagnosis of Ocular Toxoplasmosis: a Nine-Year Retrospective Observational Study.
    Greigert V; Pfaff AW; Sauer A; Filisetti D; Candolfi E; Villard O
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31554726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical Retinitis in the Setting of Prior Cytomegalovirus Retinitis.
    Sandhu HS; Maguire AM
    JAMA Ophthalmol; 2016 Jun; 134(6):709-10. PubMed ID: 27100908
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytologic identification of Toxoplasma gondii from subretinal aspirate.
    Adán A; Sole M; Mateo C; Jean AS; Alforja S
    Acta Ophthalmol; 2012 Jun; 90(4):392-3. PubMed ID: 20456249
    [No Abstract]   [Full Text] [Related]  

  • 11. Ocular toxoplasmosis: clinical features and prognosis of 154 patients.
    Bosch-Driessen LE; Berendschot TT; Ongkosuwito JV; Rothova A
    Ophthalmology; 2002 May; 109(5):869-78. PubMed ID: 11986090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of immunoblotting (IgA and IgG) and the Goldmann-Witmer coefficient for diagnosis of ocular toxoplasmosis in immunocompetent patients.
    Mathis T; Beccat S; Sève P; Peyron F; Wallon M; Kodjikian L
    Br J Ophthalmol; 2018 Oct; 102(10):1454-1458. PubMed ID: 29343531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Toxoplasma gondii and Toxocara canis among patients with uveitis.
    Lim SJ; Lee SE; Kim SH; Hong SH; You YS; Kwon OW; Kim HS
    Ocul Immunol Inflamm; 2014 Oct; 22(5):360-6. PubMed ID: 24833105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When biology supports clinical diagnosis: review of techniques to diagnose ocular toxoplasmosis.
    Greigert V; Di Foggia E; Filisetti D; Villard O; Pfaff AW; Sauer A; Candolfi E
    Br J Ophthalmol; 2019 Jul; 103(7):1008-1012. PubMed ID: 31088793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Ocular Toxoplasmosis Presenting to Uveitis Services in a Non-endemic Setting.
    Bhikoo R; Damato EM; Guest S; Sims J
    Korean J Ophthalmol; 2019 Dec; 33(6):514-519. PubMed ID: 31833248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of visual field over 6 months after active ocular toxoplasmosis.
    Blot J; Aptel F; Chumpitazi BFF; Gain P; Vasseneix C; Savy O; Bouillet L; Pelloux H; Chiquet C
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1481-1488. PubMed ID: 31037491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal detachment associated with ocular toxoplasmosis.
    Faridi A; Yeh S; Suhler EB; Smith JR; Flaxel CJ
    Retina; 2015 Feb; 35(2):358-63. PubMed ID: 25127047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral maculopathy in a patient with ataxia telangiectasia.
    Gioia LV; Bonsall D; Moffett K; Leys M
    J AAPOS; 2016 Feb; 20(1):85-8. PubMed ID: 26917084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral neuroretinitis in a 6-year-old boy with acquired toxoplasmosis.
    Perrotta S; Nobili B; Grassia C; Sebastiani A; Parmeggiani F; Costagliola C
    Arch Ophthalmol; 2003 Oct; 121(10):1493-6. PubMed ID: 14557195
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of toxoplasma retinochoroiditis during pregnancy and evaluation of ocular findings in newborns.
    Türkcü FM; Şahin A; Yüksel H; Çınar Y; Cingü K; Altındağ S; Deveci Ö; Özkurt Z; Çaça İ
    Int Ophthalmol; 2017 Jun; 37(3):559-563. PubMed ID: 27480335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.